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Chlamydiae are obligate intracellular bacterial pathogens, and as such are sensitive to
alterations in the cellular physiology of their hosts. Chlamydial infections often cause
pathologic consequences due to prolonged localized inflammation. Considerable advances
have been made in the last few years regarding our understanding of how two key
inflammation-associated signaling pathways influence the biology of Chlamydia infections:
inflammation regulating purinergic signaling pathways significantly impact intracellular
chlamydial development, and inflammasome activation modulates both chlamydial
growth and infection mediated pro-inflammatory cytokine production. We review here
elements of both pathways, presenting the latest developments contributing to our un-
derstanding of how chlamydial infections are influenced by inflammasomes and puri-
nergic signaling.The bacterial family Chlamydiaceae includes several species
which promiscuously or sporadically infect humans. Chla-
mydia trachomatis is the most common nationally notifiable
infection in the USA [1], the most common bacterial cause of
sexually transmitted infection worldwide [2], and also a
prominent cause of preventable blindness following repeated
conjunctival infections in the developing world [3]. C. tracho-
matis can also cause pneumonia in infants following exposureedical Sciences, Univers
80 2095; fax: þ1 415 780
. Ojcius).
g Gung University.
s work.
ublishing services by Else
/by-nc-nd/4.0/).during birth [4]. Chlamydophila pneumoniae is one of the leading
causes of pneumonia in the developed world [5] and may in-
crease the risk of developing atherosclerotic lesions in coro-
nary artery disease [6]. Chlamydophila psittaci, while primarily
an avian pathogen, sporadically causes human pneumonia
[7,8]. Chlamydophila abortus and Chlamydophila caviae zoonotic
infections have been reported in humans but are rare [9,10].
Untreated C. trachomatis genital tract infection in womenmayity of the Pacific, Arthur Dugoni School of Dentistry, 155 5th St,
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tubes, with the associated chronic inflammation leading to
pelvic inflammatory disease (PID), which may also cause
miscarriage [11], ectopic pregnancy [12], or tubal scarring and
infertility [13]. Repeated and chronic infection of the con-
junctiva with C. trachomatis leads to recruitment of lympho-
cytes and the formation of follicles and inflammation
mediated conjunctival thickening, which subsequently cau-
ses the deformation of the eyelids and corneal damage via
scraping of the cornea by in-turned eyelashes [14]. Pneumonia
caused by C. pneumoniae develops slowly and leads to
inflammation of the lungs but with limited production of
purulent sputum. C. pneumoniae also causes infections of the
upper respiratory tract including pharyngitis, sinusitis, and
bronchitis. Inflammation due to repeated infections with C.
pneumoniae, or unrecognized and untreated infections, may
contribute to chronic obstructive pulmonary disorder (COPD)
[15,16]. Human disease following infection with Chlamydiaceae
species bears a consistent hallmark: chronic, localized
inflammation.
Two major pathways relevant to the induction and regu-
lation of localized inflammation have recently received
considerable research emphasis and have been demonstrated
to be particularly relevant during Chlamydia infection: puri-
nergic signaling, and the formation of macro-molecular
inflammasomes. Here we review the basic concepts of puri-
nergic signaling in the context of immune function and
inflammation regulation, and inflammasome mediated in-
flammatory cytokine production, followed by an examination
of the recent literature evaluating the impact of host puri-
nergic signaling and inflammasome activation on chlamydial
infection.Extracellular purines and purinergic receptors
A wide range of extracellular purine concentrations are
physiologically relevant [17], and they are met by a similarly
broad spectrum of sensory affinity in the purinergic receptor
families [18]. ATP is released from cells under normal physi-
ologic conditions reaching nanomolar to low micromolar
concentrations in the immediately adjacent extracellular
space [19e21]. Higher concentrations of ATP or ADP result
from various forms of cell stress [22], platelet degranulation
[23], or are present in tumor microenvironments [24]. The
concentration of ATP in cells ranges from 3 to 10mM, and thus
in the context of cell damage or necrosis the neighboring cells
are exposed to low millimolar levels of extracellular ATP and
purine metabolites. ATP may be released via degranulation in
cell types which produce ADP or ATP rich granules, via pan-
nexin channels [25,26], or following cell damage. At colonized
mucosal epithelial surfaces, ATPmay also be directly released
by bacteria [27]. ATP is also released from cervical epithelial
cells in vitro during C. trachomatis infection, particularly during
the late stages of inclusion development when there is likely
more cellular stress [28].
Receptor mediated purine signaling is an evolutionarily
conserved cellular function, and is involved in a wide variety
of physiological processes in mammals including neurologic
signaling, vascular function, and immune cell regulation.Receptors which recognize purine nucleotides and nucleo-
sides are termed purinergic receptors. Purinergic receptors are
grouped into families based on functional similarity: P1 re-
ceptors are engaged by the purine nucleoside adenosine,
while P2 receptors are activated by nucleotides and are further
subdivided into gated ion channels (P2X) or G-protein coupled
seven transmembrane receptors (P2Y).
Adenosine receptors couple via G-proteins to adenylyl
cyclase to modulate cAMP generation in cells. A1 and A3 re-
ceptors associate with Gi proteins to inhibit adenylyl cyclase
and prevent cAMP upregulation, whereas A2a and A2b re-
ceptors interact with Gs proteins to activate adenylyl cyclase,
leading to elevated intracellular cAMP. Adenosine receptors
are expressed in a wide variety of cell types, with particularly
well described roles for A1 and A3 receptors in cardiac func-
tion, and for A2a receptors in immune cell function and A2b
on epithelial and endothelial cells. A2b also mediates intra-
cellular signaling via Gq and phospholipase C [29]. Recent
excellent reviews have organized the great depth of studies
related to adenosine receptor mediated regulation of immune
cells [30,31].
P2X purinergic receptors are ligand gated ion channels
which are activated by ATP, and possibly ADP in the case of
P2X4, and are increasingly recognized to play a role in
inflammation and immune cell function [32]. There are
seven described P2X receptors, the best characterized being
P2X7. P2X7 plays a critical role in the production of IL-1b and
other inflammatory cytokines both in the context of infec-
tion and sterile inflammation [33,34]. Initial stimulation of
P2X receptors leads to the opening of small-cation perme-
able pores (approximately 0.85 nm for P2X7), while pro-
longed ligation then leads to increased permeability to larger
molecules (greater than 1 nm for P2X7) [35], either by P2X7
pore dilation or by P2X7 coupling to pannexin1 and the
pannexin pore.
P2Y receptors respond to purine and pyrimidine nucleo-
tides and mediate intracellular signaling via regulation of
cAMP or activation of PLC. Eight P2Y receptors have been
characterized (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, and
P2Y14), and while their activity relevant to inflammation and
immune cell function is less well characterized than for P2X
receptors, some P2Y receptors are expressed on immune cells
[18,36,37].
While there is nuance to the roles that purine signaling
plays in local and systemic immune regulation, in general,
ATP mediates pro-inflammatory responses, and adenosine
receptor stimulation is anti-inflammatory [38]. Thus soluble
or cell surface associated extracellular enzymes play a critical
role in determining the response to extracellular purines.
Adenine nucleotides released from cells are dephosphory-
lated by members of several families of purine enzymes to
generate adenosine. Enzymes such as CD39 (ENTPD1) and
alkaline phosphatase dephosphorylate ATP and ADP to
generate AMP, and CD73 (ecto-50-nucleotidase) or alkaline
phosphatase dephosphorylates AMP to generate adenosine.
Adenosine can be captured by adjacent cells via nucleoside
transporters for purine salvage, or metabolized by adenosine
deaminase to produce inosine. Enzymes regulating extracel-
lular purine metabolism have been more completely
described in recent reviews [39,40].
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chlamydial infection
In the last 10 years, there have been many investigations into
the impact of purinergic receptor stimulation on chlamydial
development in vitro.
After work by other groups showed that purinergic recep-
tor stimulation altered mycobacterial infection in host cells
[41,42], we demonstrated that P2X7 ligation (5 mM ATPe)
reduced growth of C. psittaci in J774macrophages, while at the
same time the chlamydial infection partially inhibited ATPe
mediated apoptosis of host cells [43]. We then demonstrated
that ATP stimulation of P2X7 on murine macrophages led to
killing of intracellular Chlamydia muridarum [44], the murine
equivalent of C. trachomatis. Ligation of P2X7 receptor with
0.5e5.0 mMATPe caused fusion of chlamydial inclusions with
host-cell lysosomes, leading to chlamydial death, an effect
which was dependent on activation of phospholipase D (PLD).
Additionally, P2X7 ligation suppresses C. muridarum infection
in the preferred target cell of genitotropic Chlamydia species e
cervical epithelial cells [45]. As was the case in murine mac-
rophages, ATPe/P2X7 mediated chlamydial inhibition in mu-
rine cervical epithelial cells was at least partially dependent
on PLD activation. In animal experiments with P2X7 wild-type
and P2X7/ mice, P2X7 expression reduced the intensity, but
not the duration, of vaginal infection, and pathology scores
based on histological evaluation of endocervix, oviduct, and
mesosalpinx tissue indicated increased inflammation in the
P2X7/ mice following chlamydial infection [45].
While millimolar concentrations of ATPe are required for
P2X7 mediated effects on Chlamydia infection, micromolar
concentrations of ADPe and ATPe reversibly inhibit chla-
mydial development in human cervical epithelial cells via
P2X4 ligation [28]. One hundred mMADPe or ATPe applied to C.
trachomatis infected epithelial cells at 1 h post-infection (hpi)
significantly inhibited chlamydial inclusion development
through 24 h of infection, although by 48 hpi inclusion
development was proceeding normally. If, however, repeated
applications of ADPe or ATPe were made, inclusion develop-
ment did not occur by 48 hpi unless themedia was changed at
24 hpi. Thus, duration of exposure to micromolar concentra-
tions of ADP or ATP determined the extent of impairment of
chlamydial development. In the context of inflammation,
ATPe (pro-inflammatory) and ADOe (anti-inflammatory) often
have paradoxical effects; however, both inhibit development
of C. trachomatis in human cervical epithelial cells at micro-
molar concentrations. ADOe suppression of chlamydial
development is reversible, and is mediated by A2b receptor
stimulation [46]. ADOe and ATPe also inhibit the development
of C. trachomatis serovar E and Chlamydia pecorum in human
epithelial cells [47]. It should be noted that two independent
investigations have also demonstrated that millimolar con-
centrations of extracellular cyclic adenosine monophosphate
(cAMP) inhibit chlamydial development, leading to the pro-
duction of aberrant chlamydial bodies [47,48]. As no receptor
for extracellular cAMP has been described, and cAMP is not
cell permeable, this effect may possibly be mediated by puri-
nergic receptor stimulation following degradation of extra-
cellular cAMP. The mechanism by which purinergicstimulation of host cells alters chlamydial development has
not been elucidated, and it is also not clear whether the al-
terations described in vitro would be deleterious or advanta-
geous for chlamydial propagation in vivo. As an obligate
intracellular bacterium with a substantially reduced genome,
chlamydiae are particularly sensitive to changes in the
metabolic environment of the host cell. Indeed, in the best
described in vitromodel of chlamydial persistence, it has been
demonstrated that IFN-g stimulation of human epithelial host
cells leads to restriction of intracellular tryptophan for which
chlamydiae are auxotrophic [49,50]. Future studies are needed
to evaluate the molecular basis for the impairment in chla-
mydial development following host cell exposure to elevated
extracellular purines.Inflammasomes and inflammation
The innate immune system mounts a rapid response to
unique molecular signatures from the invading pathogen
termed pathogen associated molecular patterns (PAMPs),
where it utilizes a set of germ-line encoded pattern recogni-
tion receptors (PRRs) to initiate a measured and appropriate
inflammatory response in order to slow down the spread of
infection and thereby allowing and contributing to the initia-
tion of adaptive immunity. Furthermore, PRRs can detect
danger signals termed danger associated molecular patterns
(DAMPs) released by damaged host cells (for a review, see Ref.
[51]). PRRs can be membrane-bound like the Toll-like re-
ceptors (TLRs) and C-type lectin receptors (CLRs), which
sample the extracellular milieu from the plasma membrane
and within endosomes, or cytosolic like the nucleotide-
binding and oligomerization domain (NOD)-like receptors
(NLRs), retinoid acid-inducible gene I (RIG-I)-like receptors
(RLRs) and AIM2-like receptors (ALRs), which survey intracel-
lular PAMPs and DAMPs (reviewed in Refs. [52e54]).
Typically, most PRRs (e.g. TLRs), following recognition of
their PAMP, initiate distinct intracellular signaling cascades,
which lead to induction of various programs of gene tran-
scription including, but not limited to, co-stimulatory mole-
cules which activate components of the adaptive immune
response, production of reactive oxygen and nitrogen species,
and expression of pro-inflammatory cytokines and chemo-
kines [53,54]. On the other hand, NLRse a family of 22 genes in
humans and 34 genes in mice ecan detect not only intracel-
lular PAMPs (e.g. NOD1, NOD2) [55], but also can sense
endogenous DAMPs [52,56,57]. These latter NLRs, which
include NLRP and NLRC proteins, are components of a
macromolecular protein complex e the inflammasome e
required for the activation of caspase-1 and the subsequent
secretion of potent pro-inflammatory cytokines, including
Interleukin (IL)-1b (IL-1b) and IL-18 (reviewed in Ref. [58]).
Due to their high pro-inflammatory potency and their
significant role in innate defense to invading pathogens,
secretion of both IL-1b and IL-18 is a highly regulated process
in order to avoid diseases associated with their excessive and
chronic production, like autoimmune disorders and septic
shock [59]. Both cytokines are produced as inactive and lead-
erless forms, pro-IL-1b and pro-IL-18, and require cleavage by
caspase-1 to promote the unconventional secretion of their
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with caspase-4 and caspase-5 in humans and caspase-11 in
mice, constitute a family of inflammatory caspases that exist
as inactive zymogens (pro-caspases). Activation of these cas-
pases requires the activation of inflammasomes, which are a
multimeric assembly of pro-caspase-1 and an NLR family
member, either directly through CARDeCARD interaction or
indirectly via the adapter protein ASC [63,64]. These studies
led the way for the identification of additional means to
nucleate the inflammasome by members of the RLR and ALR
families, and the assembly of non-canonical inflammasomes
that lead to the activation of caspase-11 in mice and caspase-
4/5 in humans.
The NLRP3 inflammasome (also known as NALP3, cry-
opyrin) is the best-characterized inflammasome to date and
can be activated by wide variety of stimuli including PAMPs,
DAMPs, pore-forming toxins, whole pathogens and environ-
mental stressors (reviewed in Refs. [65e67]). Due to the large
number of triggers and in order to prevent inadvertent acti-
vation, the NLRP3 inflammasome requires two signals for its
optimal induction. PRR agonists (e.g. LPS) provide the first
signal and cause NF-kB mediated upregulation of pro-IL-1b
and components of the inflammasome, including NLRP3 [68].
The second signal can be provided by a large repertoire of
‘danger signals’ that include host derived DAMPs (e.g. ATP,
adenosine, hyaluronan, HMGB1, gout-associated uric acid
crystals and amyloid-b fibrils [69e74]), environmental
stressors (e.g. asbestos, silica crystals [75e77]), and PAMPs
that gain access to the cytosol. These PAMPs can be derived
from bacteria (e.g. toxins, RNA:DNA hybrids, type III secretion
system effectors, cyclic-dinucleotides [58,67,70,78e85]), vi-
ruses (e.g. dsRNA, viral proteins [86e90]), fungi (e.g. hyphae,
zymosan, mannan [91e94]), or Plasmodium, a malaria causing
parasite (e.g. hemozoin [95]). Importantly, some intracellular
pathogens can activate the NLRP3 inflammasome by
providing both signals (e.g. C. trachomatis [58]).
Despite this wide array of NLRP3 activators, researchers in
the field generally agree that NLRP3 does not directly sense any
of these stimuli, but instead detects specific host-derived mo-
lecular event(s), which then cause the assembly of the NLRP3
inflammasome. These upstream molecular events can be
summarized into threemain categories. (1) Events that perturb
the homeostasis of intracellular cations, and include an in-
crease in intracellularCa2þ [79,96,97] orKþ efflux,whichusually
occurs through the activated ATP-gated ion channel P2X7 or
toxin-induced pores in plasma membrane [70,98e100]. (2)
Events that cause reactive oxygen species (ROS)-mediated
oxidative stress and mitochondrial perturbation. Although the
exact mechanism of ROS-mediated NLRP3 inflammasome
activation remains controversial, there is a general consensus
that mitochondrial ROS (mROS) production is the upstream
trigger for NLRP3 activation following stimulation with several
inducers (e.g. ATP, uric acid crystals, alum, nigericin, certain
pathogens [65,101]). Elevatedandprolonged release ofmROSby
damaged mitochondria [101] leads to oxidation of mitochon-
drial DNA, which when leaked to the cytosol binds directly to
NLRP3, thereby promoting its activation [102,103]. (3) Release of
Cathepsins from destabilized lysosomes following ‘frustrated
phagocytosis’ of relatively large ‘sterile’ molecules (e.g. silica,
alum and uric acid crystals, asbestos, amyloid-b-fibrils,malarial hemozoin [69,77]) also activate the NLRP3 inflamma-
some. Again, the exact mechanism of how this leads to NLRP3
inflammasome activation remains poorly understood.Chlamydiae and inflammasomes
In response to Chlamydia infection, epithelial cells produce pro-
inflammatory cytokines and chemokines in order to activate
and recruit innate immune cells into the site of infection [104].
These immune cells, which include dendritic cells, macro-
phages, neutrophils and natural killer cells, in turn secrete
cytokines including TNF-a and IL-1b in response to the infec-
tion [105e110]. Consistently, IL-1b deficient mice infected with
C.muridarum displayed delayed clearance of the infection [111].
However, chronic and excessive production of these pro-
inflammatory cytokines has been touted as the dominant
culprit causing the pathology associated with chlamydial in-
fections [112e115]. Consistently, caspase-1 deficient mice dis-
played reduced inflammatory damage in the urogenital tract,
suggesting that it may contribute to the pathology of infection
by Chlamydia [116]. Therefore, revealing the mechanism of IL-
1b production has important implications for understanding
pathology associated with Chlamydia infection.
Previous studies have shown that caspase-1 could be
activated during chlamydial infection [107,109,111,116,117].
Indeed, C. trachomatis infection of cervical epithelial cells
caused caspase-1 activation in a manner dependent on NLRP3
inflammasome activation [58]. Subsequent studies showed
that human monocytic cell lines infected with C. trachomatis
and C. muridarum secreted IL-1b following caspase-1 activa-
tion in an NLRP3-dependent fashion [78], while C. pneumoniae
was the most potent inducer of IL-1b secretion in bone
marrow derived murine macrophages [118]. These studies
showed that Chlamydia infection alone was sufficient for
inflammasome-dependent caspase-1 activation likely
because an active Chlamydia infection can provide both signal
one via the TLR2/MyD88 axis [119e121] in addition to signal
two, activating caspase-1. The mechanism whereby chla-
mydial infections provide the second signal for NLRP3
inflammasome activation was thoroughly investigated. C.
trachomatis induced inflammasome activation is dependent
on Kþ efflux [58] although the role of the P2X7 receptor, which
is required for Kþ efflux mediated inflammasome activation
[122] and plays an important role in Chlamydia infection [45],
remains to be investigated. Chlamydia-induced loss of intra-
cellular potassium seems to trigger production of ROS, which
appears to be essential for proper activation of the NLRP3
inflammasome [67]. Importantly, the mitochondrial associ-
ated protein, NLRX1, plays an important role inmediating ROS
production following infection with C. trachomatis [78]. More-
over, C. pneumoniae mediated capase-1 activation required
lysosomal acidification and cathepsin B release [118]. The
ability of chlamydiae to activate the inflammasome is
dependent on the chlamydial type III secretion system (T3SS)
[58]. Intriguingly, a chlamydial plasmid encoded protein,
pORF5 (a.k.a. pgp3), which is secreted into the host cytosol
[123], might play a role in inflammasome activation [124].
Finally, the Rho family GTPase, Rac1, was shown to play a role
in C. pneumoniae induced inflammasome activation [125].
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Fig. 1 e Purinergic receptor stimulation and inflammasome activation alter chlamydial development. Prolonged adenosine
exposure suppresses chlamydial development via stimulation of host Gs protein- and adenylyl cyclase-coupled A2b receptors,
and ADP or ATP mediated activation of P2X4 and P2X7 receptors also leads to reduced chlamydial growth or P2X7 mediated
chlamydial killing, depending on the concentration of purine nucleotides and host cell type. Assembly of pro-caspase-1, NLR-
family member sensor proteins, and ASC adaptor proteins into multimeric inflammasomes is required to generate active
caspase-1, and follows combinatorial signaling events activating multiple upstream pathways, which may include ATP
stimulation of P2X7 receptors, or other DAMP-dependent signaling pathways. Inflammatory triggers such as lipopolysaccharide
(LPS) activation of TLR4 leads to production of pro-IL-1b, but inflammasome mediated production of active caspase-1 is
required for generation of secreted pro-inflammatory IL-1b. Inflammasome activation mediated cleavage of pro-caspase-1,
yielding active caspase-1, also contributes directly to growth of intracellular chlamydiae.
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infection is still controversial. In a mouse model of C. pneu-
moniae lung infection, results showed that caspase-1 deficient
mice displayed delayed pulmonary bacterial clearance of
infection, which was associated with increased mortality
compared to wild type mice, thereby indicating that inflam-
masome activation has an important role in the host response
to the infection [83]. On the other hand, lung fibroblasts from
ASC/ and caspase/ mice displayed resistance to infection
by C. trachomatis, a result which was recapitulated by the
caspase-1 inhibitor, YVAD [126]. In agreement, a recent report
showed that IL-10 mediated increase in tubal damage and
infertility in Chlamydia-infected mice is mediated by its ability
to enhance NLRP3 inflammasome activation in infected DCs
[127]. Furthermore, in vivo challenge with C. muridarum in IL-
1R deficient mice showed that, while IL-1b plays an impor-
tant role for clearance of genital chlamydial infection,infection of NLRP3/ and ASC/ mice showed that the
inflammasome plays a limited role in this model [128].
Chlamydia is described as the ‘perfect pathogen’ due to its
ability to evade host-cell defenses and utilize host resources to
promote its own growth [129e131]. Consistently, Chlamydia
subverts host lipids from the Golgi by inducing caspase-
mediated fragmentation of the Golgi apparatus [132]. Intrigu-
ingly, inflammasome-mediated caspase-1 activation
following C. trachomatis infection is required for optimal
intracellular growth of this pathogen [58]. Similarly, bone-
marrow derived macrophages from NLRP3, ASC or caspase-1
deficient mice showed severely impaired intracellular
growth of C. pneumoniae [133]. Intriguingly, both the caspase-1
inhibitor, YVAD, and caspase-4/5 (murine caspase-11 ortho-
log) inhibitor, WEHD, inhibited chlamydial growth, suggesting
possible roles for both caspase-1 and non-canonical caspases
(caspase-4/5 or caspase-11) in this process [58]. In fact, a
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which promotes caspase-11-dependent pyroptosis, might
play a partial role in regulating the kinetics of inflammasome
activation and affecting the ratio of IL-1b vs IL-18 production
following C. muridarum infection [134]. Furthermore, treat-
ment with probenecid, a pannexin-1 channel blocker that
inhibits P2X7 receptor mediated inflammasome activation
following Kþ efflux [135], directly inhibits chlamydial devel-
opment in a dose-dependent and reversiblemanner, although
a direct role for pannexin-1 is not clear [136].
In conclusion, although results from different laboratories
show consistently that an NLRP3 inflammasome is activated
by infection with different species of Chlamydia and that the
inflammasome may be involved in the immune response to
infection, much remains to be known of the effects that both
canonical and non-canonical inflammasomes may have on
metabolism of infected cells [Fig. 1]. In particular, elucidation
of the mechanism through which Chlamydia-mediated
caspase-1 activation may stimulate lipid metabolism for the
purpose of aiding chlamydial growth is an unexplored topic
and interesting avenue of future research.Conflicts of interest
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